The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).
Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.
LP3 will provide capabilities within protein production, biophysical characterization and protein structure determination to help VIGILANT achieve its goals.
VIGILANT: Targeting ER Import And Activation Of Viral Glycoproteins: Towards Broad-Spectrum Antivirals
LP3 will provide capabilities within protein production, biophysical characterization and protein structure determination to a new EU research project developing broad-spectrum antiviral drugs. For more details on VIGILANT please see the initial press release (External Link) by the German Primate Center.
This work is funded by the European Commission [Horizon Europe, VIGILANT (101041799)]
